Li Chuanhong, Deng Yong, Liao Rui, Zhang Leida, Gu Yongpeng
Department of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, 400038, Chongqing, China.
Heliyon. 2024 Mar 31;10(7):e28877. doi: 10.1016/j.heliyon.2024.e28877. eCollection 2024 Apr 15.
To develop and validate nomograms for predicting the OS and CSS of patients with Solitary Hepatocellular Carcinoma (HCC).
Using the TRIPOD guidelines, this study identified 5206 patients in the Surveillance, Epidemiology, and End Results (SEER) 17 registry database. All patients were randomly divided in a ratio of 7:3 into a training cohort (n = 3646) and a validation cohort (n = 1560), and the Chinese independent cohort (n = 307) constituted the external validation group. The prognosis-related risk factors were selected using univariate Cox regression analysis, and the independent prognostic factors of OS and CSS were identified using the Lasso-Cox regression model. The nomograms for predicting the OS and CSS of the patients were constructed based on the identified prognostic factors. Their prediction ability was evaluated using the concordance index (C-index), receiver operating characteristic (ROC) curve, and calibration curve in both the training and validation cohorts.
We identified factors that predict OS and CSS and constructed two nomograms based on the data. The ROC analysis, C-index analysis, and calibration analysis indicated that the two nomograms performed well over the 1, 3, and 5-year OS and CSS periods in both the training and validation cohorts. Additionally, these results were confirmed in the external validation group. Decision curve analysis (DCA) demonstrated that the two nomograms were clinically valuable and superior to the TNM stage system.
We established and validated nomograms to predict 1,3, and 5-year OS and CSS in solitary HCC patients, and our results may also be helpful for clinical decision-making.
开发并验证用于预测孤立性肝细胞癌(HCC)患者总生存期(OS)和癌症特异性生存期(CSS)的列线图。
依据TRIPOD指南,本研究在监测、流行病学和最终结果(SEER)17登记数据库中识别出5206例患者。所有患者按7:3的比例随机分为训练队列(n = 3646)和验证队列(n = 1560),中国独立队列(n = 307)构成外部验证组。采用单因素Cox回归分析选择预后相关危险因素,使用Lasso - Cox回归模型识别OS和CSS的独立预后因素。基于识别出的预后因素构建预测患者OS和CSS的列线图。在训练队列和验证队列中,使用一致性指数(C指数)、受试者操作特征(ROC)曲线和校准曲线评估其预测能力。
我们识别出了预测OS和CSS的因素,并基于这些数据构建了两个列线图。ROC分析、C指数分析和校准分析表明,这两个列线图在训练队列和验证队列的1年、3年和5年OS及CSS期表现良好。此外,这些结果在外部验证组中得到了证实。决策曲线分析(DCA)表明,这两个列线图具有临床价值且优于TNM分期系统。
我们建立并验证了用于预测孤立性HCC患者1年、3年和5年OS及CSS的列线图,我们的结果可能也有助于临床决策。